Bladder cancer is a highly treatable disease if diagnosed early, and at Aster, we offer robotic, organ-preserving, and systemic therapies to optimize survival and quality of life.

Robotic Radical Cystectomy with Urinary Reconstruction

• The most advanced surgical approach for invasive bladder cancer.
• Performed using robotic-assisted surgery, allowing for precision removal of the bladder while reducing blood loss and enhancing recovery.
• Urinary reconstruction options include:
  • Neobladder reconstruction – A new bladder is created from the intestine, allowing patients to urinate normally.
  • Ileal conduit urinary diversion – A segment of intestine is used to direct urine to an external stoma.
  • Continent urinary reservoir (Indiana Pouch) – A pouch is created from intestines, allowing catheterized urine drainage.

Transurethral Resection of Bladder Tumor (TURBT) with Blue-Light Cystoscopy

• A minimally invasive procedure that allows for early-stage tumor removal without major surgery.
• Blue-light cystoscopy & Narrow Band Imaging (NBI) increase tumor detection rates, reducing recurrence risks.

Intravesical Therapy (BCG, Chemotherapy)

• Bacillus Calmette-Guerin (BCG) therapy is the gold standard for treating non-muscle invasive bladder cancer.
• Intravesical chemotherapy may also be used to reduce recurrence and progression rates.

Systemic Therapy for Advanced Bladder Cancer

• Platinum-based chemotherapy remains the standard for metastatic bladder cancer.
• Immunotherapy (Checkpoint Inhibitors like Atezolizumab, Pembrolizumab) offers a new approach for chemotherapy-resistant bladder cancer.